Galena Biopharma Investor Claims Stock Votes Miscounted
An investor in Galena Biopharma Inc. launched a putative class action in the Delaware Chancery Court late Thursday, claiming that at two shareholder meetings, the company improperly counted stockholder votes and...To view the full article, register now.
Already a subscriber? Click here to view full article